Perceptive Advisors LLC 13D and 13G filings for enVVeno Medical Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:50 pm Purchase | 2024-09-30 | 13G | enVVeno Medical Corporation NVNO | Perceptive Advisors LLC | 53,406 9.900% | 13,557 (+34.02%) | Filing |
| 2024-02-23 4:16 pm Unchanged | 2024-02-23 | 13G | enVVeno Medical Corporation NVNO | Perceptive Advisors LLC | 39,849 9.900% | 0 (Unchanged) | Filing |
| 2024-02-14 4:38 pm Purchase | 2023-12-31 | 13G | enVVeno Medical Corporation NVNO | Perceptive Advisors LLC | 39,849 9.900% | 13,063 (+48.77%) | Filing |
| 2023-02-14 2:31 pm Sale | 2022-12-31 | 13G | enVVeno Medical Corporation NVNO | Perceptive Advisors LLC | 26,786 9.900% | -478 (-1.75%) | Filing |
| 2022-02-14 4:38 pm Purchase | 2021-12-31 | 13G | enVVeno Medical Corporation NVNO | Perceptive Advisors LLC | 27,264 9.900% | 27,264 (New Position) | Filing |